In humans, LIPG has been linked to metabolic syndrome [20], including inflammation, excessive obesity, atherosclerosis [21], hypertension [22], depression [23], leukemia [24], cancer (stomach cancer, lung cancer [25], breast cancer, ovarian cancer, colon cancer, cervical cancer, cervical cancer) [19,26], and other diseases due to its role in lipid metabolism and cell proliferation. Here, LIPG is linked to breast carcinoma.